Yarrow Bioscience, Inc YARW

25.54 (0.53) (2.03%) as of 25 Sep
Market cap
$246.0M
P/E
0.0×

A Cash Flow Statement is a financial report that details the cash inflows and outflows of a company over a specific period. It is divided into three sections: operating activities, investing activities, and financing activities. This statement helps assess the company’s liquidity, solvency, and overall financial health. By tracking cash movements, it provides insights into the company's ability to generate cash to fund operations, pay debts, and invest in growth. Businesses and investors use it to evaluate the sustainability of a company's cash flow and its financial stability.

Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Net Income
(18.71) (21.46) (26.48) (33.67)

+8 more TTM periods

Depreciation & Amortization
(0.24) (0.45) (0.75) (1.21)
Non Cash Items (Other)
1.93 2.02 2.31 2.48
Accounts Receivable Change
— 5.49 4.52 2.93
Change in payables and accrued liability
(4.26) (10.98) (12.31) (8.46)
Change in other assets and liabilities
0.40 — (0.10) (0.12)
Operating Cash Flow
(16.93) (25.74) (33.12) (38.36)
Short Term Investments Change (Net)
87.07 — 68.30 102.28
Long-Term Investments Change (Net)
— (53.15) (46.25) —
Investing cash flow
17.86 22.24 37.37 41.65
Other financial activities
(0.05) (0.07) (0.14) (0.26)
Financing cash flow
(0.05) (0.07) (0.14) (0.26)
Change in Cash
0.88 (3.58) 4.10 3.03
Beginning Cash
24.03 24.03 19.93 19.93
Ending Cash
24.91 20.45 24.03 22.95
Stock Based Compensation
1.93 2.02 2.31 2.48
Dividends Paid (Common)
0.00 0.00 0.00 0.00
Assets Liabilities Change (Total)
0.09 (5.86) (8.19) (5.96)
Investments Change (Net)
17.86 22.24 37.37 41.76

Fold the line items

In millions of $ except per-share values · columns are period end dates